Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Mason Carrico is an analyst at Stephens & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
06/27/2024 | HOLX | Buy Now | Hologic | $74.25 | 17.17% | → $87 | Initiates | → Overweight | Get Alert |
05/24/2024 | GH | Buy Now | Guardant Health | $28.49 | 54.44% | → $44 | Reiterates | Overweight → Overweight | Get Alert |
05/13/2024 | CDNA | Buy Now | CareDx | $15.23 | 18.19% | $15 → $18 | Maintains | Overweight | Get Alert |
05/07/2024 | ILMN | Buy Now | Illumina | $104.38 | 62.87% | → $170 | Reiterates | Overweight → Overweight | Get Alert |
04/19/2024 | DMTK | Buy Now | DermTech | $0.10 | 1478.95% | → $1.5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
04/17/2024 | OCX | Buy Now | OncoCyte | $2.83 | 41.42% | → $4 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
04/17/2024 | CDNA | Buy Now | CareDx | $15.23 | -1.51% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
04/10/2024 | ILMN | Buy Now | Illumina | $104.38 | 62.87% | → $170 | Reiterates | Overweight → Overweight | Get Alert |
03/05/2024 | DMTK | Buy Now | DermTech | $0.10 | 1478.95% | $2.5 → $1.5 | Maintains | Equal-Weight | Get Alert |
02/14/2024 | ILMN | Buy Now | Illumina | $104.38 | 62.87% | → $170 | Reiterates | Overweight → Overweight | Get Alert |
01/30/2024 | NTRA | Buy Now | Natera | $107.70 | -27.58% | → $78 | Reiterates | Overweight → Overweight | Get Alert |
01/17/2024 | NTRA | Buy Now | Natera | $107.70 | -27.58% | → $78 | Reiterates | Overweight → Overweight | Get Alert |
12/14/2023 | ILMN | Buy Now | Illumina | $104.38 | 62.87% | → $170 | Initiates | → Overweight | Get Alert |
12/14/2023 | PACB | Buy Now | Pacific Biosciences | $1.36 | 708.82% | → $11 | Initiates | → Overweight | Get Alert |
12/14/2023 | CTKB | Buy Now | Cytek Biosciences | $5.58 | 61.29% | → $9 | Initiates | → Overweight | Get Alert |
11/13/2023 | AKYA | Buy Now | Akoya Biosciences | $2.34 | 284.62% | $14 → $9 | Maintains | Overweight | Get Alert |
11/09/2023 | CDNA | Buy Now | CareDx | $15.23 | -34.34% | → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
10/10/2023 | VCYT | Buy Now | Veracyte | $21.67 | 56.9% | → $34 | Reiterates | Overweight → Overweight | Get Alert |
09/26/2023 | CDNA | Buy Now | CareDx | $15.23 | -34.34% | → $10 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
08/08/2023 | AKYA | Buy Now | Akoya Biosciences | $2.34 | 583.76% | → $16 | Reiterates | Overweight → Overweight | Get Alert |
07/06/2023 | CSTL | Buy Now | Castle Biosciences | $21.77 | 69.96% | → $37 | Reiterates | Overweight → Overweight | Get Alert |
05/18/2023 | TXG | Buy Now | 10x Genomics | $19.45 | 234.19% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
05/08/2023 | VCYT | Buy Now | Veracyte | $21.67 | 38.44% | → $30 | Reiterates | → Overweight | Get Alert |
05/08/2023 | CSTL | Buy Now | Castle Biosciences | $21.77 | 88.33% | → $41 | Reiterates | → Overweight | Get Alert |
05/04/2023 | MYGN | Buy Now | Myriad Genetics | $24.46 | -1.88% | → $24 | Reiterates | → Equal-Weight | Get Alert |
05/04/2023 | CSTL | Buy Now | Castle Biosciences | $21.77 | 88.33% | → $41 | Reiterates | → Overweight | Get Alert |
05/04/2023 | TXG | Buy Now | 10x Genomics | $19.45 | 234.19% | → $65 | Reiterates | → Overweight | Get Alert |
03/31/2023 | TXG | Buy Now | 10x Genomics | $19.45 | 234.19% | → $65 | Initiates | → Overweight | Get Alert |
03/21/2023 | AKYA | Buy Now | Akoya Biosciences | $2.34 | 583.76% | → $16 | Reiterates | → Overweight | Get Alert |
03/07/2023 | CDNA | Buy Now | CareDx | $15.23 | -40.91% | $19 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
03/06/2023 | MYGN | Buy Now | Myriad Genetics | $24.46 | -1.88% | $17 → $24 | Maintains | Equal-Weight | Get Alert |
03/02/2023 | CSTL | Buy Now | Castle Biosciences | $21.77 | 88.33% | → $41 | Reiterates | → Overweight | Get Alert |
02/28/2023 | CDNA | Buy Now | CareDx | $15.23 | 24.75% | → $19 | Reiterates | → Overweight | Get Alert |
02/16/2023 | GH | Buy Now | Guardant Health | $28.49 | 121.13% | → $63 | Reiterates | → Overweight | Get Alert |
02/16/2023 | CDNA | Buy Now | CareDx | $15.23 | 24.75% | → $19 | Reiterates | → Overweight | Get Alert |
11/09/2022 | DMTK | Buy Now | DermTech | $0.10 | 5163.16% | $16 → $5 | Maintains | Overweight | Get Alert |
11/07/2022 | GH | Buy Now | Guardant Health | $28.49 | 215.9% | $99 → $90 | Maintains | Overweight | Get Alert |
10/06/2022 | GH | Buy Now | Guardant Health | $28.49 | 247.49% | → $99 | Initiates | → Overweight | Get Alert |
10/06/2022 | AKYA | Buy Now | Akoya Biosciences | $2.34 | 583.76% | → $16 | Initiates | → Overweight | Get Alert |
10/06/2022 | MYGN | Buy Now | Myriad Genetics | $24.46 | -10.06% | → $22 | Initiates | → Equal-Weight | Get Alert |
05/24/2022 | OCX | Buy Now | OncoCyte | $2.83 | — | — | Downgrade | Overweight → Equal-Weight | Get Alert |
05/05/2022 | VCYT | Buy Now | Veracyte | $21.67 | 38.44% | $44 → $30 | Maintains | Overweight | Get Alert |
04/25/2022 | CDNA | Buy Now | CareDx | $15.23 | 228.3% | → $50 | Initiates | → Overweight | Get Alert |
04/25/2022 | NTRA | Buy Now | Natera | $107.70 | -49.86% | → $54 | Initiates | → Overweight | Get Alert |
03/02/2022 | VCYT | Buy Now | Veracyte | $21.67 | 103.05% | $52 → $44 | Maintains | Overweight | Get Alert |
01/07/2022 | CSTL | Buy Now | Castle Biosciences | $21.77 | 171.02% | → $59 | Initiates | → Overweight | Get Alert |
01/07/2022 | DMTK | Buy Now | DermTech | $0.10 | — | — | Initiates | → Overweight | Get Alert |
01/07/2022 | OCX | Buy Now | OncoCyte | $2.83 | 9.6% | → $62 | Initiates | → Overweight | Get Alert |
01/07/2022 | VCYT | Buy Now | Veracyte | $21.67 | 139.96% | → $52 | Initiates | → Overweight | Get Alert |